The following articles (labelled with PubMed ID or TBD) are for your review
| PMID | Data | Article Title | Organization |
|---|
| 19959361 |
2 |
Novel enoyl-ACP reductase (FabI) potential inhibitors of Escherichia coli from Chinese medicine monomers. |
Huazhong Agricultural University |
| 17892940 |
54 |
Phenylimidazole derivatives as specific inhibitors of bacterial enoyl-acyl carrier protein reductase FabK. |
Meiji Seika Kaisha |
| 17263522 |
40 |
Green tea catechins potentiate triclosan binding to enoyl-ACP reductase from Plasmodium falciparum (PfENR). |
National Institute of Immunology |
| 23806111 |
5 |
Potential of lichen secondary metabolites against Plasmodium liver stage parasites with FAS-II as the potential target. |
University of London |
| 19682901 |
20 |
Spiro-naphthyridinone piperidines as inhibitors of S. aureus and E. coli enoyl-ACP reductase (FabI). |
Affinium Pharmaceuticals |
| 19682900 |
15 |
2,3,4,5-Tetrahydro-1H-pyrido[2,3-b and e][1,4]diazepines as inhibitors of the bacterial enoyl ACP reductase, FabI. |
Affinium Pharmaceuticals |
| 18251493 |
27 |
Azetidine based transition state analogue inhibitors of N-ribosyl hydrolases and phosphorylases. |
Industrial Research |
| 17676727 |
12 |
Targeting plague virulence factors: a combined machine learning method and multiple conformational virtual screening for the discovery of Yersinia protein kinase A inhibitors. |
The Rockefeller University |
| 14718923 |
12 |
Structural basis for dipeptide amide isoform-selective inhibition of neuronal nitric oxide synthase. |
University of California Irvine |
Search and Browse
